Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA(®))

CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (NCT01243424) is an ongoing, randomized trial in subjects with early type 2 diabetes and increased cardiovascular risk or established complications that will determine the long-term cardiovascular impact of linagliptin...

Descripción completa

Detalles Bibliográficos
Autores principales: Marx, Nikolaus, Rosenstock, Julio, Kahn, Steven E, Zinman, Bernard, Kastelein, John J, Lachin, John M, Espeland, Mark A, Bluhmki, Erich, Mattheus, Michaela, Ryckaert, Bart, Patel, Sanjay, Johansen, Odd Erik, Woerle, Hans-Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Clinical Trial Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390606/
https://www.ncbi.nlm.nih.gov/pubmed/25780262
http://dx.doi.org/10.1177/1479164115570301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390606/
https://www.ncbi.nlm.nih.gov/pubmed/25780262
http://dx.doi.org/10.1177/1479164115570301

Ejemplares similares